RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Nunzia Pharmaceutical Stock

Nunzia Pharmaceutical Stocks 2024

Nunzia Pharmaceutical Stocks

305.38 M

Ticker

NUNZ

ISIN

US67097W1027

In 2024, Nunzia Pharmaceutical had 305.38 M outstanding stocks, a 7.19% change from the 284.89 M stocks in the previous year.

The Nunzia Pharmaceutical Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2021305.38
2020284.89
20180.02
20170.02
20160.02
20150.02
20140.02
20130.02
20120.02
20110.02
20100.02
2009-
2008-
2007-
2006-
2005-
2004-
2003-
2002-
2001-

Nunzia Pharmaceutical shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Nunzia Pharmaceutical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Nunzia Pharmaceutical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Nunzia Pharmaceutical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Nunzia Pharmaceutical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Nunzia Pharmaceutical Aktienanalyse

What does Nunzia Pharmaceutical do?

Nunzia Pharmaceuticals Corp is an international pharmaceutical company specializing in the development and marketing of innovative and effective drugs and medical devices. The company was founded in 2010 and is headquartered in California, USA. The business model of Nunzia Pharmaceuticals is focused on researching diseases that have been difficult or impossible to therapeutically treat in the past. The company is constantly working to develop new drugs and devices that prove to be effective treatment options. Nunzia Pharmaceuticals places great importance on comprehensive clinical trials to ensure the safety and efficacy of its products. In addition to researching and developing new medical solutions, Nunzia Pharmaceuticals has also developed a variety of medical devices that are available on the market. These devices offer innovative and effective treatment options for a variety of diseases that can improve patients' quality of life. Nunzia Pharmaceuticals is divided into different divisions in order to focus research and development on different areas. These divisions are oncology, neurology, cardiology, and orthopedics. In oncology, the company is working to develop new drugs that provide effective treatment options for various types of cancer. In neurology, the company is focused on researching treatment options for neurodegenerative diseases such as Alzheimer's and Parkinson's. In cardiology, Nunzia Pharmaceuticals is involved in the development of drugs and devices that prevent the onset of cardiovascular diseases. In orthopedics, the company has developed a variety of medical devices that improve the quality of life for patients with bone or joint diseases. An example of an innovative drug from Nunzia Pharmaceuticals is Alpharolix, which is used to treat certain types of cancer. This drug has proven to be very effective and is used worldwide to help many patients with this difficult condition. Another innovative product from Nunzia Pharmaceuticals is the carpal metacarpal joint prosthesis system, which provides improved quality of life for patients with advanced joint diseases. Over the years, Nunzia Pharmaceuticals has achieved many successes and has become a leading company in the field of medical research and development. The company has filed numerous patents and introduced a variety of medical innovations to the market. Today, the name Nunzia is globally recognized for quality, effectiveness, and innovation in medical research and development. Overall, Nunzia Pharmaceuticals is a very important player in the market of medical research and development. The company has established itself as a reliable partner for doctors, medical facilities, and patients in recent years and has set a goal to develop further groundbreaking innovations to effectively treat diseases worldwide. Nunzia Pharmaceutical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Nunzia Pharmaceutical's Shares Outstanding

Nunzia Pharmaceutical's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Nunzia Pharmaceutical’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Nunzia Pharmaceutical’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Nunzia Pharmaceutical’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Nunzia Pharmaceutical stock

How many stocks are there of Nunzia Pharmaceutical?

The current number of stocks of Nunzia Pharmaceutical is 305.38 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Nunzia Pharmaceutical are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Nunzia Pharmaceutical evolved in recent years?

The number of shares of Nunzia Pharmaceutical has increased by 7.19% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Nunzia Pharmaceutical as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Nunzia Pharmaceutical?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Nunzia Pharmaceutical pay?

Over the past 12 months, Nunzia Pharmaceutical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nunzia Pharmaceutical is expected to pay a dividend of 0 USD.

What is the dividend yield of Nunzia Pharmaceutical?

The current dividend yield of Nunzia Pharmaceutical is .

When does Nunzia Pharmaceutical pay dividends?

Nunzia Pharmaceutical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Nunzia Pharmaceutical?

Nunzia Pharmaceutical paid dividends every year for the past 0 years.

What is the dividend of Nunzia Pharmaceutical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Nunzia Pharmaceutical located?

Nunzia Pharmaceutical is assigned to the '-' sector.

Wann musste ich die Aktien von Nunzia Pharmaceutical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nunzia Pharmaceutical from 9/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/28/2024.

When did Nunzia Pharmaceutical pay the last dividend?

The last dividend was paid out on 9/28/2024.

What was the dividend of Nunzia Pharmaceutical in the year 2023?

In the year 2023, Nunzia Pharmaceutical distributed 0 USD as dividends.

In which currency does Nunzia Pharmaceutical pay out the dividend?

The dividends of Nunzia Pharmaceutical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Nunzia Pharmaceutical

Our stock analysis for Nunzia Pharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nunzia Pharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.